A recent study by Pan et al. classified TP53 mutations into gain-of-function (GOF) and non-gain-of-function (non-GOF), and showed that TP53-GOF mutation was associated with worse OS in patients with left-sided but not in right-sided metastatic colorectal cancer [28]. This evidence concerns the gene TP53 and metastatic colorectal cancer.